A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples